Compare Alcon AG (ALC) vs Lowe`s Companies Inc (LOW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Lowe`s Companies Inc — how do they compare? Alcon AG trades at $66.96 (market cap $32.69B), while Lowe`s Companies Inc trades at $213.54 (market cap $123.86B). The key difference: Lowe`s Companies Inc is far larger — about 3.8× Alcon AG's market cap, and Lowe`s Companies Inc pays the higher dividend (2.26%). Which is the better fit depends on your goals.
| ALC | LOW | |
|---|---|---|
Market Cap | $32.69B | $123.86B |
Sector | Health | Consumer Cyclical |
52-Week High | $92.22 | $287.39 |
52-Week Low | $62.02 | $206.62 |
Enterprise Value | $36.28B | $165.61B |
Dividend Yield | 0.54% | 2.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Lowe's (LOW) trades at $220.9, down 2.9% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings beats and a 60.79% buy rating from analysts support optimism, though revenue has declined from $96.2B in 2022 to $83.7B in 2025. The stock's P/E of 18.92 and net income margin of 7.51% reflect solid profitability, while dividend increases counter earlier Wall Street skepticism about payout sustainability.
The outlook is positive with a $260.88 consensus price target, but risks include high debt levels, competitive pressure from Home Depot, and macroeconomic sensitivity. Earnings growth and professional market expansion are key catalysts, though inflation and housing market softness pose headwinds for shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →
